Tibor Gajdics
Directeur/Bestuurslid bij GOLDEN AGE EXPLORATION LTD.
Vermogen: 48 501 $ op 31-05-2024
Momenteel actieve connecties
| Naam | Geslacht | Leeftijd | Verwante bedrijven | Samenwerking |
|---|---|---|---|---|
| Kevin Hanson | M | 67 | 8 jaar | |
| Ian Hollis Mann | M | 66 |
KOP Therapeutics Corp.
 KOP Therapeutics Corp. BiotechnologyHealth Technology KOP Therapeutics Corp. operates as a biotechnology company which focuses on the validation and commercialization of its newly discovered genomic drug platform. The company was founded in 2018 and is headquartered in Vancouver, Canada. | 12 jaar |
| Angela Holowaychuk | F | 41 | 6 jaar | |
| Mark Redcliffe | M | - |
KOP Therapeutics Corp.
KOP Therapeutics Corp. BiotechnologyHealth Technology KOP Therapeutics Corp. operates as a biotechnology company which focuses on the validation and commercialization of its newly discovered genomic drug platform. The company was founded in 2018 and is headquartered in Vancouver, Canada. | - |
| Ehsan Salmabadi | M | 41 | 2 jaar | |
| Aziz-Ur Rehman | M | 51 |
KOP Therapeutics Corp.
KOP Therapeutics Corp. BiotechnologyHealth Technology KOP Therapeutics Corp. operates as a biotechnology company which focuses on the validation and commercialization of its newly discovered genomic drug platform. The company was founded in 2018 and is headquartered in Vancouver, Canada. | 3 jaar |
| Marco Strub | M | 68 |
KOP Therapeutics Corp.
KOP Therapeutics Corp. BiotechnologyHealth Technology KOP Therapeutics Corp. operates as a biotechnology company which focuses on the validation and commercialization of its newly discovered genomic drug platform. The company was founded in 2018 and is headquartered in Vancouver, Canada. | - |
| Jakson Inwentash | M | 30 |
KOP Therapeutics Corp.
KOP Therapeutics Corp. BiotechnologyHealth Technology KOP Therapeutics Corp. operates as a biotechnology company which focuses on the validation and commercialization of its newly discovered genomic drug platform. The company was founded in 2018 and is headquartered in Vancouver, Canada. | 2 jaar |
| Joyce Heinzerling Davis | F | - |
KOP Therapeutics Corp.
KOP Therapeutics Corp. BiotechnologyHealth Technology KOP Therapeutics Corp. operates as a biotechnology company which focuses on the validation and commercialization of its newly discovered genomic drug platform. The company was founded in 2018 and is headquartered in Vancouver, Canada. | 5 jaar |
Relatiegrafiek
Connectie in verschillende bedrijven
Oude connecties
| Naam | Geslacht | Leeftijd | Verwante bedrijven | Samenwerking |
|---|---|---|---|---|
| Simon Moore | M | - | - | |
| Chrisilios Kyriakou | M | 70 | - | |
| Garry Stock | M | - | 1 jaar | |
| Garry Stock | M | 56 | 1 jaar | |
| David Rokoss | M | - | - | |
| Owen C. King | M | - | 1 jaar | |
| Andrew Wilkins | M | 64 | - | |
| Emma Fairhurst | F | - | - | |
| Rich Wheeless | M | - | - | |
| Peter Wielgosz | M | - | - | |
| Justin Corinella | M | - | 1 jaar |
Statistieken
| Land | Connecties | % van het totaal |
|---|---|---|
| Canada | 20 | 100.00% |
Ouderdom van de connecties
Actief
Verleden
Man
Vrouw
Besturend
Uitvoerend
Oorsprong van de connecties
- Beurs
- Insiders
- Tibor Gajdics
- Persoonlijk netwerk
